紫光國微(002049.SZ)一度下跌近6% 股價創逾3個月新低
格隆匯10月22日丨繼昨日跌停後,紫光國微(002049.SZ)今早再度低開低走,盤中一度跌5.85%報107元,股價創今年7月初以來新低,市值649億元。公司昨日公佈三季報顯示,1-9月份營收23.2億元,同比下滑6.78%;歸屬於上市公司股東淨利潤6.85億元,同比增87.51%;第三季度營收8.56億元,同比下滑7.96%;歸屬於上市公司股東淨利潤2.83億元,同比增64.05%。還值得注意的是,從機構持倉情況來看,2020年上半年,合計185家基金持有紫光國微11.33%股份,到了三季度,持倉紫光國微基金數量下滑至6家,持倉比例下降至7.85%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.